Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma

Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma

(2021) Gloria Iacoboni et al.   Cancer Medicine

Cost-Effectiveness of Tisagenlecleucel in Paediatric Acute Lymphoblastic Leukaemia (pALL) and Adult Diffuse Large B-Cell Lymphoma (DLBCL) in Switzerland

(2021) Maziar Moradi-Lakeh et al.   ADVANCES IN THERAPY

Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States

(2021) Cynthia Z. Qi et al.   CLINICAL THERAPEUTICS

Perceptions of community hematologists/oncologists on barriers to chimeric antigen receptor T-cell therapy for the treatment of diffuse large B-cell lymphoma

(2020) Ajeet Gajra et al.   Immunotherapy

Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma

(2018) Hongfei Ji et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

(2018) Shannon L. Maude et al.   NEW ENGLAND JOURNAL OF MEDICINE

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival

(2018) Colm Keane et al.   Oncotarget

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

(2018) Stephen J. Schuster et al.   NEW ENGLAND JOURNAL OF MEDICINE

PCN177 - COST-EFFECTIVENESS OF TISAGENLECLEUCEL FOR ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA : A CANADIAN SOCIETAL PERSPECTIVE

(2018) H. Yang et al.   VALUE IN HEALTH

Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L

(2016) Rujiao Liu et al.   TUMOR BIOLOGY

Estimating Tumor Growth Rates In Vivo

(2015) Anne Talkington et al.   BULLETIN OF MATHEMATICAL BIOLOGY

The highest prognostic impact of LDH among International Prognostic Indices (IPIs): an explorative study of five IPI factors among patients with DLBCL in the era of rituximab

(2014) J. H. Park et al.   ANNALS OF HEMATOLOGY

Prognostic Role of Serum Lactate Dehydrogenase Beyond Initial Diagnosis: A Retrospective Analysis of Patients with Diffuse Large B Cell Lymphoma

(2013) Junshik Hong et al.   ACTA HAEMATOLOGICA